AQR Arbitrage’s SpringWorks Therapeutics SWTX Stock Holding History

AQR Arbitrage’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,319,782	Closed	-$62M	–	496
2025 Q2	$62M	Buy	+1,319,782	New	+$58.7M	1.42%	15

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's SWTX Position: Q3 2025 in Review

AQR Arbitrage sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 1,319,782 shares — an estimated $62M sold.

AQR Arbitrage first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $62M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

AQR Arbitrage reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
AQR Arbitrage sold 1,319,782 SpringWorks Therapeutics shares in Q3 2025, an estimated $62M.
AQR Arbitrage first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
AQR Arbitrage's SpringWorks Therapeutics position peaked at $62M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on AQR Arbitrage's 13F filing for Q3 2025, filed 14 Nov 2025.